GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (FRA:HPX) » Definitions » Liabilities-to-Assets

Hisamitsu Pharmaceutical Co (FRA:HPX) Liabilities-to-Assets : 0.19 (As of Feb. 2024)


View and export this data going back to . Start your Free Trial

What is Hisamitsu Pharmaceutical Co Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Hisamitsu Pharmaceutical Co's Total Liabilities for the quarter that ended in Feb. 2024 was €382.3 Mil. Hisamitsu Pharmaceutical Co's Total Assets for the quarter that ended in Feb. 2024 was €2,037.1 Mil. Therefore, Hisamitsu Pharmaceutical Co's Liabilities-to-Assets Ratio for the quarter that ended in Feb. 2024 was 0.19.


Hisamitsu Pharmaceutical Co Liabilities-to-Assets Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Liabilities-to-Assets Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.15 0.16 0.18 0.19

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.18 0.20 0.19 0.19

Competitive Comparison of Hisamitsu Pharmaceutical Co's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Liabilities-to-Assets falls into.



Hisamitsu Pharmaceutical Co Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Hisamitsu Pharmaceutical Co's Liabilities-to-Assets Ratio for the fiscal year that ended in Feb. 2024 is calculated as:

Liabilities-to-Assets (A: Feb. 2024 )=Total Liabilities/Total Assets
=382.306/2037.083
=0.19

Hisamitsu Pharmaceutical Co's Liabilities-to-Assets Ratio for the quarter that ended in Feb. 2024 is calculated as

Liabilities-to-Assets (Q: Feb. 2024 )=Total Liabilities/Total Assets
=382.306/2037.083
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hisamitsu Pharmaceutical Co  (FRA:HPX) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Hisamitsu Pharmaceutical Co Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (FRA:HPX) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.